---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/32014876.md"
description: "$Sarepta Therap(SRPT.US) The stock price plunge is purely due to market panic. The FDA review is just a routine procedure. Sarepta's therapy data is solid, and its long-term value remains. Investors have overreacted."
datetime: "2025-07-20T17:20:29.000Z"
locales:
  - [en](https://longbridge.com/en/topics/32014876.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/32014876.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/32014876.md)
author: "[得民心者得天下](https://longbridge.com/en/profiles/18490426.md)"
---

# $Sarepta Therap(SRPT.US) The stock price plunge is…


### Related Stocks

- [SRPT.US](https://longbridge.com/en/quote/SRPT.US.md)

## Comments (3)

- **巴比龙 · 2025-07-20T23:58:30.000Z**: It could drop by more than 90%. The US stock market doesn't make sense.
  - **黄昏拂晓时分** (2025-07-21T01:27:04.000Z): Yes, mainly because of the long-term losses, it has been halved several times from the peak.
- **黄昏拂晓时分 · 2025-07-20T23:06:11.000Z**: A company that keeps losing money, it's correct to look at the stock in the long term, but when there are no short-term positives, you should still cut losses and exit, after all, this is the US stock market.